Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
2,716
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

Emin Kansuf Hacettepe University Cancer Institute, Ankara, TurkeyCorrespondence[email protected]
View further author information
,
David Warde Division of Nephrology and Hypertension, Apheresis Unit, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Amber P. Sancheze Division of Nephrology and Hypertension, Apheresis Unit, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Robyn Cunarde Division of Nephrology and Hypertension, Apheresis Unit, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Mutlu Hayranf Hacettepe University Cancer Institute, Ankara, TurkeyView further author information
,
Beril Huseyinf Hacettepe University Cancer Institute, Ankara, TurkeyView further author information
,
Majella Vaughana Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Grace Kud Genentech, Inc.South San Francisco, CA, USAView further author information
,
Peter Curtinc City of Hope Medical Center, Duarte, CA, USAView further author information
,
Carolyn Mulroneya Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Caitlin Costelloa Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Januario E. Castrob Cellular Therapy Program, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Matthew Wieduwilta Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Sue Corringhama Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Anita Ihasz-Davisa Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
,
Connie Nelsona Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
&
Edward D. Balla Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USAView further author information
 show all
Pages 785-794 | Published online: 08 Jul 2022

Figures & data

Table 1. Patient and transplant characteristics.

Table 2. Chronic GVHD characteristics (N = 53).

Figure 1. Cumulative probability of overall response (CR/PR) after ECP.

Figure 1. Cumulative probability of overall response (CR/PR) after ECP.

Table 3. Response to ECP treatment in chronic GVHD (N = 53).

Table 4. Best organ responses to ECP treatment.

Table 5. Response to ECP treatment – duration of ECP(months).

Figure 2. Cumulative probability of overall response (CR/PR) after ECP by sex.

Figure 2. Cumulative probability of overall response (CR/PR) after ECP by sex.

Figure 3. Overall survival of patients following ECP treatment after chronic GVHD.

Figure 3. Overall survival of patients following ECP treatment after chronic GVHD.

Table 6. Factors affecting response (CR/PR) to ECP.

Table 7. Factors affecting response to ECP (overall survival).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.